goes to show it's not just about sales. at least 30% drop in stock since december!!!
based on our pipeline alone who are the idiots designing these stupid clinical trials in CMR?
poa and company meetings they love to post headlines about investor reactions to Novo drugs. When it goes south, Lars gets on stage to say it's not about what investors think. ON NO NO
